A combination of controlled vocabulary terms and free-text keywords relating to “systemic lupus erythematosus,” “immune thrombocytopenia,” “rituximab,” “belimumab,” and “thrombopoietin receptor agonists” was employed. The gene discussed is MPL; the disease is systemic lupus erythematosus.